These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 27080105)

  • 41. Differential requirement for NF-kappa B family members in control of helminth infection and intestinal inflammation.
    Artis D; Shapira S; Mason N; Speirs KM; Goldschmidt M; Caamaño J; Liou HC; Hunter CA; Scott P
    J Immunol; 2002 Oct; 169(8):4481-7. PubMed ID: 12370384
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nod2: The intestinal gate keeper.
    Al Nabhani Z; Dietrich G; Hugot JP; Barreau F
    PLoS Pathog; 2017 Mar; 13(3):e1006177. PubMed ID: 28253332
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Whipworm-Associated Intestinal Microbiome Members Consistent Across Both Human and Mouse Hosts.
    Rosa BA; Snowden C; Martin J; Fischer K; Kupritz J; Beshah E; Supali T; Gankpala L; Fischer PU; Urban JF; Mitreva M
    Front Cell Infect Microbiol; 2021; 11():637570. PubMed ID: 33777847
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Intestinal flora and Crohn's disease].
    Desreumaux P; Colombel JF
    Ann Pharm Fr; 2003 Jul; 61(4):276-81. PubMed ID: 12843962
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intestinal Bacteria Composition and Translocation of Bacteria in Inflammatory Bowel Disease.
    Vrakas S; Mountzouris KC; Michalopoulos G; Karamanolis G; Papatheodoridis G; Tzathas C; Gazouli M
    PLoS One; 2017; 12(1):e0170034. PubMed ID: 28099495
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Crohn's disease susceptibility gene interactions, a NOD to the newcomer ATG16L1.
    Cadwell K
    Gastroenterology; 2010 Nov; 139(5):1448-50. PubMed ID: 20875485
    [No Abstract]   [Full Text] [Related]  

  • 47. Crohn's disease as an immune deficiency?
    Coulombe F; Behr MA
    Lancet; 2009 Sep; 374(9692):769-70. PubMed ID: 19733770
    [No Abstract]   [Full Text] [Related]  

  • 48. Trichuris suis ova: testing a helminth-based therapy as an extension of the hygiene hypothesis.
    Jouvin MH; Kinet JP
    J Allergy Clin Immunol; 2012 Jul; 130(1):3-10; quiz 11-2. PubMed ID: 22742834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autophagy and inflammatory bowel disease: Association between variants of the autophagy-related IRGM gene and susceptibility to Crohn's disease.
    Rufini S; Ciccacci C; Di Fusco D; Ruffa A; Pallone F; Novelli G; Biancone L; Borgiani P
    Dig Liver Dis; 2015 Sep; 47(9):744-50. PubMed ID: 26066377
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Is Crohn's disease due to defective immunity?
    Korzenik JR
    Gut; 2007 Jan; 56(1):2-5. PubMed ID: 17172582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Regulation of bone mass by the gut microbiota is dependent on NOD1 and NOD2 signaling.
    Ohlsson C; Nigro G; Boneca IG; Bäckhed F; Sansonetti P; Sjögren K
    Cell Immunol; 2017 Jul; 317():55-58. PubMed ID: 28576260
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immune-driven alterations in mucin sulphation is an important mediator of Trichuris muris helminth expulsion.
    Hasnain SZ; Dawson PA; Lourie R; Hutson P; Tong H; Grencis RK; McGuckin MA; Thornton DJ
    PLoS Pathog; 2017 Feb; 13(2):e1006218. PubMed ID: 28192541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Crohn's disease - etiopathogenetic factors].
    Kupka T; Símová J; Martínek L; Svoboda P; Klvaňa P; Bojková M; Uvírová M; Dovrtělová L; Dítě P
    Vnitr Lek; 2014; 60(7-8):635-9. PubMed ID: 25130642
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reduced alpha-defensin expression is associated with inflammation and not NOD2 mutation status in ileal Crohn's disease.
    Simms LA; Doecke JD; Walsh MD; Huang N; Fowler EV; Radford-Smith GL
    Gut; 2008 Jul; 57(7):903-10. PubMed ID: 18305068
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.
    Bianchi V; Maconi G; Ardizzone S; Colombo E; Ferrara E; Russo A; Tenchini ML; Porro GB
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):217-23. PubMed ID: 17301648
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NOD2 mutations are associated with the development of intestinal failure in the absence of Crohn's disease.
    Schäffler H; Schneider N; Hsieh CJ; Reiner J; Nadalin S; Witte M; Königsrainer A; Blumenstock G; Lamprecht G
    Clin Nutr; 2013 Dec; 32(6):1029-35. PubMed ID: 23562557
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The importance of gut microbiota in mediating the effect of NOD2 defects in inflammatory bowel disease.
    Rogler G
    Gut; 2010 Feb; 59(2):153-4. PubMed ID: 20176638
    [No Abstract]   [Full Text] [Related]  

  • 58. Suppression of inflammation by helminths: a role for the gut microbiota?
    Giacomin P; Croese J; Krause L; Loukas A; Cantacessi C
    Philos Trans R Soc Lond B Biol Sci; 2015 Aug; 370(1675):. PubMed ID: 26150662
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of Fidaxomicin versus Vancomycin on Susceptibility to Intestinal Colonization with Vancomycin-Resistant Enterococci and Klebsiella pneumoniae in Mice.
    Deshpande A; Hurless K; Cadnum JL; Chesnel L; Gao L; Chan L; Kundrapu S; Polinkovsky A; Donskey CJ
    Antimicrob Agents Chemother; 2016 Jul; 60(7):3988-93. PubMed ID: 27090175
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
    Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
    Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.